GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 207 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $27,322,000 | +3315.2% | 401,197 | +2665.2% | 0.06% | +5500.0% |
Q3 2020 | $800,000 | -39.3% | 14,509 | -30.6% | 0.00% | -50.0% |
Q2 2020 | $1,319,000 | -11.6% | 20,904 | -28.4% | 0.00% | 0.0% |
Q1 2020 | $1,492,000 | -28.9% | 29,199 | +10.6% | 0.00% | 0.0% |
Q4 2019 | $2,098,000 | +409.2% | 26,389 | +211.0% | 0.00% | – |
Q3 2019 | $412,000 | -73.0% | 8,484 | -70.7% | 0.00% | -100.0% |
Q2 2019 | $1,525,000 | +193.3% | 29,000 | +195.4% | 0.00% | 0.0% |
Q1 2019 | $520,000 | -66.5% | 9,817 | -74.3% | 0.00% | -50.0% |
Q4 2018 | $1,553,000 | -4.0% | 38,129 | -10.4% | 0.00% | +100.0% |
Q3 2018 | $1,617,000 | -24.2% | 42,542 | -9.8% | 0.00% | -50.0% |
Q2 2018 | $2,132,000 | +14.3% | 47,183 | +22.2% | 0.00% | 0.0% |
Q1 2018 | $1,865,000 | -1.9% | 38,605 | -20.1% | 0.00% | +100.0% |
Q4 2017 | $1,902,000 | – | 48,335 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
Grace Capital | 244,914 | $12,882,000 | 6.14% |
Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |